Episode Summary

Why are we running out of antibiotics? A look at the pharmaceutical development of one of the most life-saving class of drugs.

Topics discussed:

  • The reasons behind the stagnant and declining antibiotic development pipeline
  • New initiatives focused on stimulating the antibiotic market
  • Strategies to spur the antibiotic development


  • Helen Boucher, MD. Professor of Medicine and Chief, Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Editor of AAC
  • Karen Bush, PhD. Professor of Practice & Interim Director, Biotechnology Program Indiana University. Former Editor AAC.

Visit aac.asm.org to browse issues and/or submit a manuscript.

Subscribe to Editors in Conversation (free) on Apple Podcasts, Google Podcasts, Android, Spotify.